Why Muscle and Strength Fade Faster After Menopause: The Collagen-Signal Connection

Why does strength fade faster than muscle size?

Ask most people what causes weakness with age and they will say muscle loss. That is only part of the picture.

Strength is not just a measure of how much muscle tissue you carry. It is also a measure of how efficiently force transmits through that tissue, from the muscle fiber, through the surrounding connective tissue, to the tendon, and out to the joint. Researchers studying this gap have increasingly pointed at that connective tissue layer, not the fibers, as a major piece of the mismatch.

The scaffold inside the muscle

Every muscle fiber sits inside a wrapping of connective tissue called the endomysium, and bundles of fibers sit inside a thicker wrapping called the perimysium. Both are made mostly of collagen.

Think of a bundle of steel cables inside a sleeve. The cables can be fully intact, and the whole assembly still loses transmission efficiency if the sleeve around them degrades. That sleeve is what a growing body of research is now focused on.

The scaffold does more than one job, and each job shows up differently on a strength test.

• Transmits the force a muscle fiber generates out to the tendon
• Keeps individual fibers aligned so force does not scatter sideways
• Provides the structural anchor new muscle protein is built onto
• Determines how much of a fiber's raw output actually reaches the joint

What does estrogen have to do with connective tissue?

Estrogen signaling reaches further than the reproductive system most people associate it with. It also plays a role in how connective tissue is maintained throughout the body, bone included.

When estrogen falls at menopause, the signal that keeps collagen turnover running at a healthy pace falls with it. Bone shows this clearly on a scan. Muscle connective tissue shows it more quietly, as a loss of transmission efficiency that reads on paper as declining grip strength and functional power.

Why this looks different from ordinary aging

Men lose strength with age too, on a slower and steadier curve tied to overall aging. Women see a distinct acceleration around the menopause transition that does not match a simple aging timeline, which is one of the clues pointing researchers toward a hormonal signal rather than time alone.

• The connective tissue wrapping muscle fibers is mostly collagen
• Collagen turnover is influenced by estrogen signaling
• Estrogen falls sharply and permanently at menopause
• Strength decline that outpaces muscle loss is the resulting signature

What did the human muscle research actually find?

Das and colleagues (2016) ran an 8 week human trial, 500 milligrams a day, with biopsies taken from the vastus lateralis, a major thigh muscle, before and after. The trial found a 17 gene cluster tied to connective tissue rebuilding switched on, with the largest collagen gene changes around 5 fold.

That is a gene expression outcome, not a strength outcome, and the trial ran in a small mixed sex group of 16 people. The honest phrase for what it shows is that shilajit switched on a cluster of genes involved in rebuilding connective tissue, never that it builds muscle.

The trial run specifically in women

One trial answers a question the 2016 study leaves open.

A separate 14 week trial by Das and colleagues (2019) tested the same fulvic acid compound in women specifically, 250 milligrams twice daily. It measured skin, not thigh muscle, but it found the identical pattern, improved perfusion and reactivated blood vessel and connective tissue genes.

That trial closes part of the gap the 2016 study leaves open. It is direct human evidence, in women, that the mechanism is active, even though the tissue measured was skin rather than muscle.

The strength trial, with its limit stated plainly

Keller and colleagues (2019) ran an 8 week randomised controlled trial in 63 active young men. The group taking 500 milligrams a day held onto more of their maximum strength after a fatiguing protocol, losing roughly 9% versus 16 to 17% in the placebo group, alongside a lower reading on a connective tissue breakdown marker.

This trial is strong on design, randomised, controlled, a real strength outcome, and it has 1 clear limit. It ran in young men, not postmenopausal women, so the honest read is that it shows the mechanism can protect strength under fatigue in a body that already has healthy estrogen levels, not that it replicates in a postmenopausal population.

Does protein alone solve this?

Protein matters, and nothing here argues against eating enough of it. It supplies the amino acids that both muscle fiber and connective tissue are built from.

What protein alone does not supply is the signal that decides how efficiently that material gets assembled into new, functional connective tissue. Supplying more bricks does not speed up a crew that has gone quiet.

Resistance training remains the single most proven lever for strength at any age, and nothing in this article is a substitute for it. The research above describes a separate, additional piece, the biological signal layer underneath the mechanical one.

What is the honest limit of this evidence?

There is no dedicated shilajit trial run in postmenopausal women measuring muscle strength directly, and that gap should be stated plainly rather than talked around.

What exists instead is 3 separate pieces, and each carries its own limit.

• Das 2016: human muscle biopsy, gene expression only, mixed sex, small n=16
• Das 2019: human trial run in women, but measured skin rather than muscle
• Keller 2019: real strength outcome, randomised and controlled, but young men only
• No single trial combines a postmenopausal population with a direct strength measurement

Read together they form a consistent mechanism story. They do not add up to a single clean trial proving the outcome in the exact population this article is written for, and no honest summary claims that they do.

Across every human shilajit study published so far, not one serious adverse event has been reported, a safety record that holds regardless of which outcome a given trial was measuring.

Sourcing and purity still matter

Optimum sources from the Altai mountains, purifies each batch, and publishes a full lab report testing for all 4 major heavy metals on every batch sold, the same purified form used in the trials cited here.

Pure Altai shilajit, tested in full

Sourced from the Altai mountains, purified, and tested for all 4 heavy metals with the report published for every batch. Family owned out of Florida. If you want the food form source behind the research in this article, here is .

See Optimum Shilajit